Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson’s disease-Reference-Cited by-同舟云学术

Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson’s disease

Published:2018-06 Issue: Volume:127 Page:204-212
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Kalaria Dhaval R.,Singhal Mayank^ORCID,Patravale Vandana,Merino Virginia,Kalia Yogeshvar N.

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference46 articles.

1. Diagnosis and initial management of Parkinson's disease;Nutt;N. Engl. J. Med.,2005

2. The etiopathogenesis of Parkinson disease and suggestions for future research. Part I;Litvan;J. Neuropathol. Exp. Neurol.,2007

3. Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004;Goetz;Mov. Disord.,2005

4. The scientific and clinical basis for the treatment of Parkinson disease (2009);Olanow;Neurology,2009

5. Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease;Piercey;Clin. Neuropharmacol.,1998

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in transdermal drug delivery: A comprehensive review of physical penetration enhancement techniques;International Journal of Pharmaceutics;2024-03

2. Pharmacokinetics and Pharmacodynamics of Nanocarriers and Novel Drug Delivery Systems;Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From Basic Concepts to Applications;2024

3. Delivering hydrosoluble compounds through the skin: what are the chances?;International Journal of Pharmaceutics;2023-11

4. Iontophoresis for the cutaneous delivery of nanoentraped drugs;Expert Opinion on Drug Delivery;2023-05-03

5. Recent Options and Techniques to Assess Improved Bioavailability: In Vitro and Ex Vivo Methods;Pharmaceutics;2023-04-04